VORSCHAU

PRESSETERMINE

AKTUELLES PRESSEFOTO

IR Nachrichten
24.12.2024 15:18 UKO Microshops AG
24.12.2024 07:30 Zumtobel Group AG
23.12.2024 18:30 Peach Property Group AG


WETTER
Graz: bedeckt
24°
Innsbruck: Regen
22°
Linz: Regen
22°
Wien: bedeckt
20°
© wetter.net

Stadtname / PLZ

AKTIENKURSE
 
ADHOC
Mo, 04.11.2024 19:00
Meldung drucken Artikel weiterleiten
pta20241104028
Business news for the stock market
Pressefach Pressefach

QLUPOD AG: Successful appearance at the OLMA trade fair

Successful participation of Qlupod AG at OLMA 2024

Herisau (pta028/04.11.2024/19:00) - Qlupod AG can draw a positive balance after participating in this year's OLMA, Switzerland's largest public exhibition for agriculture and nutrition with more than 330,000 visitors. Our company's stand was very busy from day one, with interest in our QluPod health monitor far exceeding our expectations. The compact device, which measures five important vital signs, represents a significant innovation for the health market and was extremely well received by visitors and health experts.

Large crowds and keen interest in the QluPod health monitor

"We are impressed by the great interest that the QluPod aroused at OLMA," says Nikola Trajanov, Interim CEO and Partner of Qlupod AG. "Our stand was full almost all the time and it was once again clear that our solution is of great interest to both end customers and medical professionals."

At the trade fair, the Qlupod AG team presented the individual functions of the QluPod, which was designed as a health monitor for measuring five to six vital signs. Thanks to its ease of use and precise measurements, the device provides a solid basis for continuous health monitoring in everyday life. Visitors had the opportunity to measure their vital signs on site and experience the simple operation of the QluPod for themselves. The demonstrations attracted numerous curious end customers, who were overwhelmingly positive about the health monitor.

In addition to private users, experts and potential partners from various areas of healthcare and care were also among the visitors to our stand. These included doctors, carers and representatives from care facilities such as Spitex. Due to the digitalisation of healthcare, the demand for innovative and user-friendly measuring devices such as the QluPod is constantly increasing. Medical practices and institutions are increasingly relying on digital and mobile technologies to improve the quality of care and health monitoring of patients. The OLMA offers an ideal platform to deepen this dialogue and to emphasise the QluPod's unique range of functions as a USP on the European market.

Valuable contacts for future collaborations

Our stand was also well attended by investors and business partners of Qlupod AG. Participation in the trade fair provided an excellent opportunity to inform current and potential investors about the company's developments and progress. The exchange provided insights into the positive feedback from users and showed that confidence in the innovative potential of the health monitor is justified. Thanks to our presence at OLMA, we were also able to make numerous new contacts, opening up valuable opportunities for future co-operation in the health and care sector.

"OLMA 2024 was a complete success for us. The high number of visitors and the great interest in our QluPod Health Monitor confirm that we are on the right track," summarises Nikola Trajanov. "We are confident that we will be able to develop valuable partnerships from the many conversations we have had and contacts we have made, which will further promote the establishment of the QluPod on the market, also in conjunction with the QluApp Pro and other apps."

About Qlupod:

Qlupod AG is a start-up company in the field of telemedicine and develops innovative solutions to make patient care efficient and cost-effective. With the QluPod device and the associated software, the company is endeavouring to shape the future of healthcare. The offering is aimed at hospitals, care facilities, medical professionals and private individuals who want to monitor their health independently.

For more information about Qlupod AG and our products, please visit our website at www.qlupod.com.

Disclaimer:

This publication constitutes neither an offer to sell nor a solicitation to buy securities. Insofar as this document contains forward-looking statements, these do not represent facts and are characterised by the words "expect", "believe", "estimate", "intend", "aim", "assume" and similar expressions. These statements express the intentions, opinions or current expectations and assumptions of Qlupod AG and are based on current plans, estimates and forecasts which Qlupod AG has made to the best of its knowledge, but do not claim to be correct in the future. Forward-looking statements are subject to risks and uncertainties that are difficult to predict and are generally beyond the control of Qlupod AG. It should be noted that actual events or developments may differ materially from the events and developments expressed or implied by such forward-looking statements.

(Ende)

Aussender: QLUPOD AG
Bahnhofstrasse 23
9100 Herisau
Schweiz
Ansprechpartner: Nikola Trajanov
Tel.: +41 71 510 05 45
E-Mail:
Website: qlupod.eu
ISIN(s): CH1222316429 (share)
Börsen: -
Weitere Handelsplätze: Regelmaessige Kursfeststellung Schweiz
QLUPOD AG
   
So wurde bewertet:
Weitersagen
Share Share |
Social Media
ETARGET

FOCUSTHEMA


SPECIALS


Werbung
middleAdvertising